Table 4.
Fever treatment by malaria test result across all private outlets
| Malaria test positive % (95% CI) N = 266 |
Malaria test negative % (95% CI) N = 250 |
Not tested % (95% CI) N = 753 |
|
|---|---|---|---|
| Any anti-malarial | 83.0 (74.6–89.0) | 14.3 (9.3–21.2) | 50.8 (44.4–57.3) |
| Any ACT | 60.0 (53.3–66.3) | 10.2 (6.5–15.5) | 42.7 (36.4–49.3) |
| QA ACT | 48.5 (41.3–55.7) | 6.6 (3.7–11.6) | 33.9 (27.7–40.7) |
| Non-quality assured ACT | 12.2 (8.1–18.1) | 3.5 (1.3–9.4) | 8.9 (5.6–13.7) |
| Non-artemisinin therapya | 14.4 (9.6–21.1) | 3.6 (1.3–9.3) | 8.4 (5.9–11.8) |
| Artemisinin monotherapyb | 14.9 (9.3–23.0) | 0.5 (0.1–3.6) | 1.1 (0.4–3.3) |
| Antibiotic | 42.5 (34.1–51.3) | 54.7 (45.7–63.4) | 24.1 (18.9–30.1) |
| Antipyretic | 78.7 (71.4–84.5) | 61.2 (50.6–70.9) | 64.9 (59.5–70.0) |
| Patient received a prescription for an anti-malarial, but did not receive an anti-malarial at the outlet (exiting without treatment) | 0.2 (0.1, 0.8) | 3.3 (0.7, 14.4) | 0.2 (<0.1, 1.8) |
aPrimarily quinine injections, tablets, syrups as well as SP tablets and a few chloroquine tablet anti-malarials
bPrimarily artemether injections